Search Within

Han Xiao

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (9)
Groups
  1. Department of Medicine (21)
  2. Epidemiology and Biostatistics (21)
  3. Genitourinary Oncology Service (21)
  4. Solid Tumor Oncology Division (21)
  5. Biostatistics Service (16)
  6. Population Sciences Research Program (10)

More Groups

People
  1. Glenn Heller (7)
  2. Michael Morris (7)
  3. Arlyn Apollo (4)
  4. Gary Deng (4)
  5. Joshua Chaim (4)
  6. Jun Mao (4)

More People

Years
  1. 2024 (5)
  2. 2023 (5)
  3. 2022 (2)
  4. 2020 (2)
  5. 2019 (1)
  6. 2018 (3)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Annals of Oncology (3)
  3. BMJ Open (1)
  4. Cancer (1)
  5. European Urology Oncology (1)
  6. Head & Neck (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (12)
  2. Oxford University Press (4)
  3. American Medical Association (1)
  4. BMJ Publishing Group Ltd. (1)
  5. Elsevier BV (1)
  6. John Wiley & Sons, Inc. (1)

More Publishers

Results (21)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical outcomes of patients with metastatic urothelial carcinoma (mUC) discontinuing enfortumab vedotin (EV) monotherapy (mono) without disease progression
    Meeting Abstract

    Sternschuss, M.; Whiting, K.; Teo, M. Y.; Bajorin, D.; Kotecha, R.; Laccetti, A. L.; Xiao, H.; Feld, E.; McHugh, D. J.; Keegan, N.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Final clinical and liquid biopsy (LBx) results of phase II trial of sacituzumab govitecan (SG) in patients (Pts) with metastatic castration resistant prostate cancer (mCRPC) progressing on androgen receptor signaling inhibitors (ARSI)
    Meeting Abstract

    Lang, J. M.; Tagawa, S. T.; Slovin, S.; Sperger, J. M.; Schehr, J. L.; Stahlfeld, C.; Hintz, A. M.; Emamekhoo, H.; Rathkopf, D.; Abida, W.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Clinical outcomes of sacituzumab govitecan (SG) after prior exposure to enfortumab vedotin (EV) in patients with metastatic urothelial carcinoma (mUC)
    Meeting Abstract

    Sternschuss, M.; Toumbacaris, N.; Das, J. P.; Powles, T.; Bajorin, D. F.; Kotecha, R. R.; Laccetti, A. L.; Xiao, H.; Feld, E.; McHugh, D. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of talazoparib and avelumab in genomically defined metastatic kidney cancer
    Journal Article

    Kotecha, R. R.; Doshi, S. D.; Knezevic, A.; Chaim, J.; Chen, Y.; Jacobi, R.; Zucker, M.; Reznik, E.; McHugh, D.; Shah, N. J.; more...
    European Urology Oncology (2024)

    Fulltext@MSK | Save
  • PRESTO: A phase III, open-label study of intensification of androgen blockade in patients with high-risk biochemically relapsed castration-sensitive prostate cancer (AFT-19)
    Journal Article

    Aggarwal, R.; Heller, G.; Hillman, D. W.; Xiao, H.; Picus, J.; Taplin, M. E.; Dorff, T.; Appleman, L.; Weckstein, D.; Patnaik, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Acupuncture vs massage for pain in patients living with advanced cancer: The IMPACT randomized clinical trial
    Journal Article

    Epstein, A. S.; Liou, K. T.; Romero, S. A. D.; Baser, R. E.; Wong, G.; Xiao, H.; Mo, Z. L.; Walker, D.; MacLeod, J.; Li, Q.; more...
    JAMA Network Open (2023)

    Fulltext@MSK | Save
  • Acupuncture versus massage for pain in patients living with advanced cancer: The IMPACT randomized clinical trial
    Meeting Abstract

    Mao, J. J.; Liou, K.; Romero, S. A. D.; Baser, R. E.; Wong, G.; Xiao, H.; Deng, G.; Mo, Z.; Walker, D.; MacLeod, J. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Depth of PSA nadir and subsequent PSA progression-free survival in patients (pts) with high-risk biochemically relapsed prostate cancer: Results from the phase 3 PRESTO study (AFT-19)
    Meeting Abstract

    Aggarwal, R. R.; Dooley, K.; Hillman, D. W.; Xiao, H.; Picus, J.; Taplin, M. E.; Dorff, T. B.; Appleman, L. J.; Weckstein, D. J.; Patnaik, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Randomized phase III study of enzalutamide compared with enzalutamide plus abiraterone for metastatic castration-resistant prostate cancer (Alliance A031201 trial)
    Journal Article

    Morris, M. J.; Heller, G.; Hillman, D. W.; Bobek, O.; Ryan, C.; Antonarakis, E. S.; Bryce, A. H.; Hahn, O.; Beltran, H.; Armstrong, A. J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Baseline characteristics associated with PSA progression-free survival in patients (pts) with high-risk biochemically relapsed prostate cancer: Results from the phase 3 PRESTO study (AFT-19)
    Meeting Abstract

    Aggarwal, R. R.; Heller, G.; Hillman, D. W.; Xiao, H.; Picus, J.; Taplin, M. E.; Dorff, T. B.; Appleman, L. J.; Weckstein, D. J.; Patnaik, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save